Alexis Bio, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Xenotherapeutics, Inc. (to 2022)
0
Ending by 2030
Oct 2039
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 5, 2027The maintenance fee for Xenotransplantation products and methods (US 11,833,270) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 9 of 9
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,799,614 | Xenotransplantation products and methods In force · From the USPTO record | In force | From the USPTO record | |
| US 10,883,084 | Personalized Cells, Tissues, and Organs for Transplantation from a Humanized, Bespoke, Designated-Pathogen Free, (N0N-HUMAN) Donor and Methods and Products Relating to Same In force · Medium confidence | In force | Medium confidence | |
| US 10,905,799 | Xenotransplantation products and methods In force · From the USPTO record | In force | From the USPTO record | |
| US 11,028,371 | Personalized Cells, Tissues, and Organs for Transplantation from a Humanized, Bespoke, Designated-Pathogen Free, (NON-HUMAN) Donor and Methods and Products Relating to Same In force · Medium confidence | In force | Medium confidence | |
| US 11,155,788 | Personalized Cells, Tissues, and Organs for Transplantation from a Humanized, Bespoke, Designated-Pathogen Free, (NON-HUMAN) Donor and Methods and Products Relating to Same In force · Medium confidence | In force | Medium confidence | |
| US 11,473,062 | Personalized Cells, Tissues, and Organs for Transplantation from a Humanized, Bespoke, Designated-Pathogen Free, (NON-HUMAN) Donor and Methods and Products Relating to Same In force · Low confidence | In force | Low confidence | |
| US 11,129,922 | Xenotransplantation products and methods In force · From the USPTO record | In force | From the USPTO record | |
| US 11,833,270 | Xenotransplantation products and methods In force · From the USPTO record | In force | From the USPTO record | |
| US 11,424,007 | Selection and monitoring methods for xenotransplantation In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 abandoned · 2 no status recorded